Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Given the associations between chronic inflammation and epithelial cancer, we studied susceptibility to skin carcinogenesis in mice deficient for the pro-inflammatory cytokine TNF-alpha (refs. 5,6). TNF-alpha(-/-) mice were resistant to development of benign and malignant skin tumors, whether induced by initiation with DMBA and promotion with TPA or by repeated dosing with DMBA. TNF-alpha(-/-) mice developed 5-10% the number of tumors developed by wild-type mice during initiation/promotion and 25% of those in wild-type mice after repeated carcinogen treatment. TNF-alpha could influence tumor and stromal cells during tumor development. The early stages of TPA promotion are characterized by keratinocyte hyperproliferation and inflammation. These were diminished in TNF-alpha(-/-) mice. TNF-alpha was extensively induced in the epidermis, but not the dermis, in TPA-treated wild-type skin, indicating that dermal inflammation is controlled by keratinocyte TNF-alpha production. Deletion of a TNF-alpha inducible chemokine also conferred some resistance to skin tumor development. TNF-alpha has little influence on later stages of carcinogenesis, as tumors in wild-type and TNF-alpha(-/-) mice had similar rates of malignant progression. These data provide evidence that a pro-inflammatory cytokine is required for de novo carcinogenesis and that TNF-alpha is important to the early stages of tumor promotion. Strategies that neutralize TNF-alpha production may be useful in cancer treatment an…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MCP1 is a critical chemoattractant responsible for the recruitment of macrophages into tumor and for angiogenesis in breast cancer [131, 132], and may contribute to indirect crosstalk between MSC and cancer cells via recruitment of tumor-resident macrophages.”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [132]
Citations
Cites
Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker
Bradley, P. P., Priebat, D. A., Christensen, R. D., & Rothstein, G. (1982) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12506462 · Cited by 3,626
Correa, P. (1992) · PubMed · Cited by 3,216
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3195 · Cited by 2,218
Pasparakis, M., Alexopoulou, L., Episkopou, V, & Kollias, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160
Self-citationLu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Self-citationEggermont, A. M., Schraffordt Koops, H., Liénard, D., Kroon, B. B., van Geel, A. N., Hoekstra, H. J., & Lejeune, F. J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2653 · Cited by 398
Genetic Polymorphisms in the Tumor Necrosis Factor Locus Influence Non-Hodgkin's Lymphoma Outcome
Warzocha, K., Ribeiro, P., Bienvenu, J., Roy, P., Charlot, C., Rigal, D., Coiffier, B., & Salles, G. (1998) · Blood · doi:10.1182/blood.v91.10.3574 · Cited by 272
Naylor, M. S., Stamp, G. W., Foulkes, W. D., Eccles, D., & Balkwill, F. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116446 · Cited by 252
Self-citationAnti-Tumor Necrosis Factor-α Therapy of Rheumatoid Arthritis
Feldmann, M., Elliott, M. J., Maini, R. N., & Woody, J. N. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60891-3 · Cited by 230
Pasparakis, M., Alexopoulou, L., Grell, M., Pfizenmaier, K., Bluethmann, H., & Kollias, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6319 · Cited by 205
Self-citation
Cited by
Items 501–600 of 838
Pten loss in Lgr5+ hair follicle stem cells promotes SCC development
Chen, H., Wang, X., Chen, Y., Han, J., Kong, D., Zhu, M., Fu, X., & Wu, Y. (2019) · Theranostics · doi:10.7150/thno.35467 · Cited by 29
Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both?
de Visser, K. E. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0501-x · Cited by 32
Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression
Simonneau, M., Frouin, É., Huguier, V., Jermidi, C., Jégou, J., Godet, J., Barra, A., Paris, I., Levillain, P., Cordier-Dirikoc, S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26355 · Cited by 27
Seeger, H., Wallwiener, D. R., & Mueck, A. O. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.07.042 · Cited by 27
A combination of E. coli DNA fragments and modified lipopolysaccharides as a cancer immunotherapy
Cho, Y. J., Ahn, B. Y., Lee, N. G., Lee, D. H., & Kim, D. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.048 · Cited by 27
Structural basis for the Helicobacter pylori-carcinogenic TNF-α-inducing protein
Tsuge, H., Tsurumura, T., Utsunomiya, H., Kise, D., Kuzuhara, T., Watanabe, T., Fujiki, H., & Suganuma, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.121 · Cited by 26
Guven‐Maiorov, E., Acuner, S. E., Keskin, Ö., Gürsoy, A., & Nussinov, R. (2014) · Cancers · doi:10.3390/cancers6020663 · Cited by 30
Hepatitis B virus X protein in liver tumor microenvironment
Fu, S., Zhou, R., Li, N., Huang, Y., & Fan, X. (2016) · Tumor Biology · doi:10.1007/s13277-016-5406-2 · Cited by 28
TCF7L1 promotes skin tumorigenesis independently of β-catenin through induction of LCN2
Ku, A. T., Shaver, T. M., Rao, A. S., Howard, J. M., Rodriguez, C. N., Miao, Q., Garcia, G. E., Le, D. N., Yang, D., Borowiak, M., et al. (2017) · eLife · doi:10.7554/elife.23242 · Cited by 27
Wang, W., Wu, J., Mukherjee, A., He, T., Wang, X., Ma, Y., & Fang, X. (2020) · The FASEB Journal · doi:10.1096/fj.202001136r · Cited by 27
Chan, E. K. L., Peace, B. E., Collins, M. H., Toney‐Earley, K., & Waltz, S. E. (2004) · Oncogene · doi:10.1038/sj.onc.1208231 · Cited by 26
Therapeutic Targets of the TNF Superfamily
Grewal, I. S. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8 · Cited by 29
Risk of malignancy among patients with rheumatic conditions
Thomas, E., Brewster, D. H., Black, R. J., & Macfarlane, G. J. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001101)88:3<497::aid-ijc27>3.0.co;2-j · Cited by 332
Baseggio, L., Bienvenu, J., Charlot, C., Picollet, J., Felman, P., Coiffier, B., & Salles, G. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(00)00672-x · Cited by 26
Etanercept and squamous cell carcinoma
Burge, D. J. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/s0190-9622(03)00811-9 · Cited by 26
Understanding the Anticancer Properties of Honey
Martinotti, S., Bonsignore, G., & Ranzato, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111724 · Cited by 29
Oncoprotein Signaling Mediates Tumor-Specific Inflammation and Enhances Tumor Progression
Pufnock, J., & Rothstein, J. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801284 · Cited by 27
Elliot, A. M., Myllymäki, H., & Feng, Y. (2020) · Cells · doi:10.3390/cells9041018 · Cited by 25
Rayó, J., Gregor, R., Jacob, N. T., Dandela, R., Dubinsky, L., Yashkin, A., Aranovich, A., Thangaraj, M., Ernst, O., Barash, E., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012529118 · Cited by 23
Anti-Tumor Necrosis Factor Therapy Inhibits Lung Metastasis in an Osteosarcoma Cell Line
Kato, H., Wakabayashi, H., Naito, Y., Kato, S., Nakagawa, T., Matsumine, A., & Sudo, A. (2014) · Oncology · doi:10.1159/000368414 · Cited by 26
Ono, R., Masaki, T., Dien, S., Yu, X., Fukunaga, A., Yodoi, J., & Nishigori, C. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2012.01566.x · Cited by 27
Timp3 Deficient Mice Show Resistance to Developing Breast Cancer
Jackson, H. W., Hojilla, C. V., Weiss, A., Sanchez, O. H., Wood, G. A., & Khokha, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120107 · Cited by 28
Vidal, M. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13280 · Cited by 31
Beyer, E. M., & MacBeath, G. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.013292 · Cited by 28
Duality of the Immune Response in Cancer: Lessons Learned from Skin
Medler, T. R., & Coussens, L. M. (2014) · Journal of Investigative Dermatology · doi:10.1038/skinbio.2014.5 · Cited by 24
Hong, H. S., Akhavan, J., Lee, S. H., Kim, R. H., Kang, M., Park, N., & Shin, K.-H. (2020) · International Journal of Oral Science · doi:10.1038/s41368-019-0069-7 · Cited by 32
Enhanced Immunotherapeutic Efficacy of Anti–PD-L1 Antibody in Combination with an EP4 Antagonist
Sajiki, Y., Konnai, S., Cai, Z., Takada, K., Okagawa, T., Maekawa, N., Fujisawa, S., Kato, Y., Suzuki, Y., Murata, S., et al. (2020) · ImmunoHorizons · doi:10.4049/immunohorizons.2000089 · Cited by 26
Plackoska, V., Shaban, D., & Nijnik, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1041010 · Cited by 27
Sasi, S. P., Bae, S., Song, J. S., Perepletchikov, A. M., Schneider, D., Carrozza, J. P., Yan, X., Kishore, R., Enderling, H., & Goukassian, D. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092373 · Cited by 22
Kammertoens, T., Qin, Z., Briesemeister, D., Bendelac, A. S., & Blankenstein, T. J. F. (2011) · International Journal of Cancer · doi:10.1002/ijc.27411 · Cited by 26
Ding, J., Huang, Y., Ning, B., Gong, W., Li, J., Wang, H., Chen, C., & Huang, C. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909787313995 · Cited by 24
Singh, A. K., Willems, E., Singh, A., Hafeez, B. B., Ong, I. M., Mehta, S. L., & Verma, A. K. (2016) · Oncotarget · doi:10.18632/oncotarget.7595 · Cited by 24
The indole compound MA-35 attenuates tumorigenesis in an inflammation-induced colon cancer model
Kanehara, K., Ohnuma, S., Kanazawa, Y., Sato, K., Kokubo, S., Suzuki, H., Karasawa, H., Suzuki, T., Suzuki, C., Naitoh, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48974-9 · Cited by 25
Sakai, H., Yamada, Y., Shimizu, M., Saito, K., Moriwaki, H., & Hara, A. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.01.014 · Cited by 23
Moslemizadeh, A., Nematollahi, M. H., Amiresmaili, S., Faramarz, S., Jafari, E., Khaksari, M., Rezaei, N., Bashiri, H., & Kheirandish, R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120744 · Cited by 26
Fawzy, R. M., AbdEl-Aziz, A., Bassiouny, K., & Fayed, A. M. (2024) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2023.100339 · Cited by 29
Rizzato, C., Canzian, F., Rudnai, P., Gurzau, E. S., Stein, A., Koppová, K., Hemminki, K., Kumar, R., & Campa, D. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr197 · Cited by 23
Hashikawa, K.-I., Katamune, C., Kusunose, N., Matsunaga, N., Koyanagi, S., & Ohdo, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-10599-1 · Cited by 22
Chadwick, J. W., Macdonald, R., Ali, A. A., Glogauer, M., & Magalhães, M. A. O. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.741013 · Cited by 30
Ba, H., Dai, Z., Zhang, Z., Zhang, P., Yin, B., Wang, J., Li, Z., & Zhou, X. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003837 · Cited by 26
Association of NALP2 polymorphism with arsenic induced skin lesions and other health effects
Bhattacharjee, P., Das, N., Chatterjee, D., Banerjee, A. M., Das, J. K., Basu, S., Banerjee, S., Majumder, P., Goswami, P., & Giri, A. K. (2013) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2013.04.010 · Cited by 22
Review Paper: The Role of Inflammation in Mouse Pulmonary Neoplasia
Bauer, A. K., & Rondini, E. A. (2009) · Veterinary Pathology · doi:10.1354/vp.08-vp-0217-b-rev · Cited by 22
Tian, W., Liu, J., PEI, B., Wang, X., Guo, Y., & Yuan, L. (2016) · Oncology Reports · doi:10.3892/or.2016.4561 · Cited by 22
The Tumor-Promoting Effect of TNF-α Involves the Induction of Secretory Leukocyte Protease Inhibitor
Devoogdt, N., Revets, H., Kindt, A., Liu, Y. Q., BAETSELIER, P. D., & Ghassabeh, G. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8046 · Cited by 23
Acquired and innate immunity to polyaromatic hydrocarbons
Yusuf, N., Timares, L., Seibert, M. D., Xu, H., & Elmets, C. A. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.009 · Cited by 22
Bocchetta, M., & Carbone, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207855 · Cited by 32
Is the Loss of pRb Essential for the Mouse Skin
Ruiz, S., Santos, M., & Paramio, J. M. (2006) · Cell Cycle · doi:10.4161/cc.5.6.2580 · Cited by 25
Wang, Y., Yang, M.-C., & Pan, M. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.09.064 · Cited by 22
Immune recognition and tumor protection
Dranoff, G. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00315-1 · Cited by 21
Evaluation of risk in chronic cutaneous inflammatory conditions for malignant transformation
Ju, T., Hernandez, L. E. D. L. C., Mohsin, N., Labib, A., Frech, F. S., & Nouri, K. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18663 · Cited by 24
Seeger, H., Wallwiener, D. R., & Mueck, A. O. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802288267 · Cited by 21
Immune System Plays an Important Role in the Success and Failure of Conventional Cancer Therapy
Gough, M. J., & Crittenden, M. R. (2012) · Immunotherapy · doi:10.2217/imt.11.157 · Cited by 25
Geer, L. A., Pycke, B. F. G., Sherer, D. M., Abulafia, O., & Halden, R. U. (2014) · Environmental Research · doi:10.1016/j.envres.2014.09.031 · Cited by 22
Salako, M. A., Kulbe, H., Ingemarsdotter, C. K., Pirlo, K. J., Williams, S. L., Lockley, M., Balkwill, F. R., & McNeish, I. A. (2010) · Molecular Therapy · doi:10.1038/mt.2010.247 · Cited by 21
Self-citationShen, J., Abel, E. L., Riggs, P. K., Repass, J. F., Hensley, S. C., Schroeder, L. J., Temple, A., Chau, A., McClellan, S. A., Rho, O., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs213 · Cited by 23
Cavigelli, S. A., Bennett, J. M., Michael, K. C., & Klein, L. C. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.10.014 · Cited by 25
Loss of TNF-α-regulated COX-2 expression in ovarian cancer cells
Yang, W.-L., Roland, I. H., Godwin, A. K., & Xu, X. (2005) · Oncogene · doi:10.1038/sj.onc.1208943 · Cited by 21
Cytokine mRNA expression in basal cell carcinoma
Gambichler, T., Skrygan, M., Hyun, J., Bechara, F. G., Tomi, N. S., Altmeyer, P. J., & Kreuter, A. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0673-1 · Cited by 24
Guo, N., Wen, Y., Wang, C., Kang, L., Wang, X., Liu, X., Soulika, A. M., Liu, B., Zhao, M., Han, X., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000166rr · Cited by 21
Protein stabilization of ITF2 by NF-κB prevents colitis-associated cancer development
Lee, M., KIM, Y., Lim, S., Shin, S.-H., Kim, I., Kim, J., Choi, M., Kim, J. H., Koh, S., Park, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38080-w · Cited by 22
Zhang, X., Ruan, Y., Li, Y., Lin, D., Liu, Z., & Quan, C. (2015) · PubMed · Cited by 22
Liu, F., Ai, F., Tian, L., Liu, S., Zhao, L., & Wang, X. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s109342 · Cited by 20
Biopsychological Stress Factors in BRCA Mutation Carriers
Wenzel, L. B., Osann, K., Lester, J., Kurz, R. N., Hsieh, S., Nelson, E. L., & Karlan, B. Y. (2012) · Psychosomatics · doi:10.1016/j.psym.2012.06.007 · Cited by 27
Genetic Analysis of Macrophage Characteristics as a Tool to Identify Tumor Susceptibility Genes
Fijneman, R. J. A., Vos, M., Berkhof, J. H., Démant, P., & Kraal, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3767 · Cited by 20
Jou, E. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00146 · Cited by 23
Ouyang, W., Hu, Y., Li, J., Ding, M., Lu, Y., Zhang, D., Yan, Y., Song, L., Qu, Q., Desai, D. H., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm115 · Cited by 21
Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing
Zins, K., & Abraham, D. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0290-4_17 · Cited by 24
Ignacio, R. M. C., Kim, C.-S., Kim, Y.-D., Lee, H., Qi, X.-F., & Kim, S. (2015) · Cytokine · doi:10.1016/j.cyto.2015.06.002 · Cited by 19
Lee, H. Y., Park, K. S., Kim, M.-K., Lee, T., Ryu, S. H., Woo, K. J., Kwon, T. K., & Bae, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.154 · Cited by 19
NEMO- and RelA-dependent NF-κB signaling promotes small cell lung cancer
Koerner, L., Schmiel, M., Yang, T.-P., Peifer, M., Buettner, R., & Pasparakis, M. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01112-5 · Cited by 22
Self-citationBald, T., Landsberg, J., Jansen, P., Gaffal, E., & Tüting, T. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1078964 · Cited by 19
Sheikholeslami, A., Nabiuni, M., & Arefian, E. (2017) · Tumor Biology · doi:10.1177/1010428317697570 · Cited by 18
Xu, T., Kong, Z., & Zhao, H. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00469 · Cited by 18
Hewala, T. I., Moneim, N. A. A. E., Ebied, S. A. E.-M., Sheta, M., Soliman, K., & Abu-Elenean, A. (2010) · British Journal of Biomedical Science · doi:10.1080/09674845.2010.11730315 · Cited by 18
Melanoma and Nonmelanoma Skin Cancers and the Immune System
Domingo, D. S., & Baron, E. D. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-77574-6_15 · Cited by 22
Tang, W., Wang, H., Ha, H., Tassi, I., Bhardwaj, R., Claudio, E., & Siebenlist, U. K. (2016) · Oncogene · doi:10.1038/onc.2016.152 · Cited by 18
Shimizu, T. (2010) · Cancers · doi:10.3390/cancers2031555 · Cited by 22
Stromal endothelin B receptor–deficiency inhibits breast cancer growth and metastasis
Binder, C. R., Hagemann, T., Sperling, S., Schulz, M., Pukrop, T., Grimshaw, M. J., & Ehrenreich, H. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0032 · Cited by 18
Ishitsuka, Y., Kawachi, Y., Maruyama, H., Taguchi, S., Fujisawa, Y., Furuta, J., Nakamura, Y., Ishii, Y., & Otsuka, F. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.189 · Cited by 21
Lafont, É. (2020) · Cancers · doi:10.3390/cancers12051113 · Cited by 18
Lian, Z., Niwa, K., Gao, J., Tagami, K., Hashimoto, M., Yokoyama, Y., Mori, H., & Tamaya, T. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00059-9 · Cited by 17
Vire, B., de Walque, S., Restouin, A., Olive, D., Lint, C. M. V., & Collette, Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007085 · Cited by 17
The safety of etanercept for the treatment of plaque psoriasis
Papp, K. A. (2007) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2007.3.2.245 · Cited by 17
Oxaliplatin and Infliximab Combination Synergizes in Inducing Colon Cancer Regression
Li, W., Xu, J., Zhao, J., & Zhang, R. (2017) · Medical Science Monitor · doi:10.12659/msm.901880 · Cited by 19
Basic Concepts of Inflammation and its Role in Carcinogenesis
Maher, S. G., & Reynolds, J. V. (2011) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-03503-6_1 · Cited by 23
The Effects of Clonal Heterogeneity on Cancer Immunosurveillance
Dijkstra, K. K., Wu, Y., & Swanton, C. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061521-101910 · Cited by 17
Facilitating Cytokine-Mediated Cancer Cell Death by Proteobacterial N-Acylhomoserine Lactones
Kravchenko, V. V., Garner, A. L., Mathison, J. C., Seit‐Nebi, A. S., Yu, J., Павловна, Г. И., Ulevitch, R. J., & Janda, K. D. (2013) · ACS Chemical Biology · doi:10.1021/cb4000184 · Cited by 16
Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression
Fan, Y.-C., Lee, K., & Tsai, Y.-C. (2020) · Biomedicines · doi:10.3390/biomedicines8120602 · Cited by 16
Joy, B., Kumar, S. N., Soumya, M. S., Radhika, A., Vibin, M., & Abraham, A. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.07.001 · Cited by 16
The role of cytokines in the regulation of drug disposition: extended functional pleiotropism?
Liptrott, N. J., & Owen, A. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.553600 · Cited by 21
Pedersen, B. K. (2007) · American Journal of Lifestyle Medicine · doi:10.1177/1559827607301410 · Cited by 16
Corsini, E., Racchi, M., Lucchi, L., Donetti, E., Bedoni, M., Viviani, B., Galli, C. L., & Marinovich, M. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08885.x · Cited by 16
Engineering cancer resistance in mice
Klatt, P. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg057 · Cited by 16
Chen, Y., Guo, Y., Li, S., Xu, J., Zhao, C., Wang, J., Yang, J., Ning, W., Qu, Y., Zhang, M., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113315 · Cited by 16
Frese‐Schaper, M., Keil, A., Yagita∥, H., Steiner, S., Falk, W., Schmid, R. A., & Frese, S. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1535-x · Cited by 15
Drosophilaas a Model System to Study Nonautonomous Mechanisms Affecting Tumour Growth and Cell Death
Parvy, J.-P., Hodgson, J. A., & Cordero, J. B. (2018) · BioMed Research International · doi:10.1155/2018/7152962 · Cited by 20
Response to TNF-α Is Increasing Along with the Progression in Barrett’s Esophagus
Chemnitzer, O., Götzel, K., Maurer, L., Dietrich, A., Eichfeld, U., Lyros, O., Jansen‐Winkeln, B., Hoffmeister, A., Gockel, I., & Thieme, R. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4821-6 · Cited by 16
Jang, J. Y., Yoon, H., Yoon, J., Kim, H. S., Lee, S. J., Kim, K. H., Kim, D., Jang, S., Han, B.-G., Lee, B. I., et al. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.010 · Cited by 15
Peterson, K. E., Hughes, S., Dimcheff, D. E., Wehrly, K., & Chesebro, B. W. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13104-13112.2004 · Cited by 16
Genetic Predisposition to Sporadic Cancer: How to Handle Major Effects of Minor Genes?
Fijneman, R. J. A. (2005) · Analytical Cellular Pathology · doi:10.1155/2005/737191 · Cited by 19
Metadata
- Authors
- Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., Kollias, G., & Balkwill, F.
- Affiliations
- Hammersmith Hospital (GB)
- Harvard University (US)
- Pasteur Hellenic Institute (GR)
- Corresponding author
- Balkwill, Frances
- ORCID
- Venue
- Nature Medicine
- Published
- 1999-07
- Volume
- 5
- Issue
- 7
- Pages
- 828-831
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1585093254
- Cited by
- 839
- References
- 21
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 8 · 2023: 20 · 2022: 15 · 2021: 19 · 2020: 26 · 2019: 18 · 2018: 16 · 2017: 19 · 2016: 37 · 2015: 32 · 2014: 46 · 2013: 44 · 2012: 41
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- TNF-α, skin carcinogenesis, TNF-alpha knockout mice, tumor promotion, 7,12-dimethylbenz(a)anthracene, tissue plasminogen activator, keratinocyte hyperproliferation, skin inflammation, chemokines, malignant progression, chronic inflammation and cancer, cancer prevention
- MeSH terms
- Animals, Crosses, Genetic, Female, Immunity, Innate, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Inbred Strains, Neoplasm Invasiveness, Neoplasm Staging, Skin, Skin Neoplasms, Tetradecanoylphorbol Acetate, Time Factors, Tumor Necrosis Factor-alpha, 9,10-Dimethyl-1,2-benzanthracene, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.